<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We sought to determine whether cerebral <z:mp ids='MP_0001845'>inflammation</z:mp> in ischemic rats was reduced by a neuroprotective action of pre-ischemic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha up-regulation, which down-regulated matrix metalloproteinase-9 activity via extracellular signal-regulated kinase 1/2 phosphorylation </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: Adult male Sprague-Dawley rats were subjected to 30 minutes of exercise on a treadmill for 3 weeks </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> was induced by a 2 hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> using an intraluminal filament </plain></SENT>
<SENT sid="3" pm="."><plain>The exercised animals were treated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha antibody, UO126 (extracellular signal-regulated kinase 1/2 inhibitor), or both UO126 and <z:chebi fb="1" ids="50845">doxycycline</z:chebi> (matrix metalloproteinase-9 inhibitor) </plain></SENT>
<SENT sid="4" pm="."><plain>Brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was assessed using Nissl staining </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0002498'>Leukocyte infiltration</z:mp> was evaluated using myeloperoxidase immunostaining </plain></SENT>
<SENT sid="6" pm="."><plain>Intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 and matrix metalloproteinase protein levels were determined by Western blot, and enzyme activity was evaluated using zymography </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There was a significant decrease in neurological deficits, brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:mp ids='MP_0002498'>leukocyte infiltration</z:mp>, in association with reduction in matrix metalloproteinase-9 and intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 expression in exercised animals </plain></SENT>
<SENT sid="8" pm="."><plain>Exercised animals treated with either <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha antibody or with UO126 showed a reversal of neurological outcome, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:mp ids='MP_0002498'>leukocyte infiltration</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Matrix metalloproteinase-9 activity was reversed, at least partially, but the intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 expression was not </plain></SENT>
<SENT sid="10" pm="."><plain>Neuroprotection remained when the exercised ischemic rats were treated with both UO126 and <z:chebi fb="1" ids="50845">doxycycline</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: These results suggest that exercise-induced up-regulation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha before <z:hpo ids='HP_0001297'>stroke</z:hpo> and extracellular signal-regulated kinase 1/2 phosphorylation play a role in decreasing <z:mp ids='MP_0001847'>brain inflammation</z:mp> by regulating matrix metalloproteinase-9 activity </plain></SENT>
</text></document>